Low calorie meal replacement plan

PreclinicalSmall molecule

Low calorie meal replacement plan is one of 28 small molecule programs targeting Heart Failure. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Heart FailureActive, not recruiting

Heart Failure With Preserved Ejection FractionRecruiting

Heart FailurePhase 2/Phase 3

Active, not recruiting

Heart Failure With Preserved Ejection FractionPreclinical

Recruiting

Competition

Competitive Landscape

687 competitors in Heart Failure

#DrugCompanyPhaseTrials

Brethine

Sanofi

Preclinical

1 2

Amidate

Pfizer

Preclinical

1 3

LCZ696

Novartis

Preclinical

15 4

Zemplar

AbbVie

Preclinical

—5

Bystolic

VVitae Pharmaceuticals Inc., an Allergan affiliate

Preclinical

4 6

Zoloft

VViatris Specialty LLC

Preclinical

2 7

Xifaxan

SSalix

Preclinical

2 8

Coumadin

AAbbott

Preclinical

1 9

Statin

Bristol-Myers Squibb

Preclinical

1 10

GLP-1

RRigshospitalet, Denmark

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Heart Failure With Preserved Ejection Fraction1 trial

A Multi-Ethnic, Multi-centre raNdomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction (AMEND-preserved)

Recruiting·UUniversity of Leicester·Preclinical·NCT05887271·63 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Low calorie meal replacement plan. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Low calorie meal replacement plan compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Low calorie meal replacement plan. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Leicester company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity of Leicester

Low calorie meal replacement plan

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Heart Failure With Preserved Ejection Fraction1 trial

References

Drug Info

Quick Facts

Related News